EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HGA Triggers SAA Aggregation and Accelerates Fibril Formation in the C20/A4 Alkaptonuria Cell Model

Pierfrancesco Mastroeni iD, Alfonso Trezza, Michela Geminiani iD, Luisa Frusciante iD, Anna Visibelli iD, Annalisa Santucci iD

Cells · 2024

DOI: 10.3390/cells13171501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Pierfrancesco Mastroeni und 5 weiteren Autor:innen. Beteiligte Einrichtung: ONE-HEALTH Lab, Department of Biotechnology, Chemistry and Pharmacy, University of Siena Via Aldo Moro, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Alkaptonuria, Serum Amyloid A Protein, Homogentisic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alkaptonuria (AKU) is a rare autosomal recessive metabolic disorder caused by mutations in the homogentisate 1,2-dioxygenase (HGD) gene, leading to the accumulation of homogentisic acid (HGA), causing severe inflammatory conditions. Recently, the presence of serum amyloid A (SAA) has been reported in AKU tissues, classifying AKU as novel secondary amyloidosis; AA amyloidosis is characterized by the extracellular tissue deposition of fibrils composed of fragments of SAA. AA amyloidosis may complicate several chronic inflammatory conditions, like rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, chronic infections, neoplasms, etc. Treatments of AA amyloidosis relieve inflammatory disorders by reducing SAA concentrations; however, no definitive therapy is currently available. SAA regulation is a crucial step to improve AA secondary amyloidosis treatments. Here, applying a comprehensive in vitro and in silico approach, we provided evidence that HGA is a disruptor modulator of SAA, able to enhance its polymerization, fibril formation, and aggregation upon SAA/SAP colocalization. In silico studies deeply dissected the SAA misfolding molecular pathway and SAA/HGA binding, suggesting novel molecular insights about it. Our results could represent an important starting point for identifying novel therapeutic strategies in AKU and AA secondary amyloidosis-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaptonuriaSerum Amyloid A ProteinHomogentisic AcidHumansProtein AggregatesAmyloidosisAmyloidModels, BiologicalHomogentisate 1,2-Dioxygenase

Stichwörter der Autor:innen

HGAalkaptonuriaamyloiddocking and molecular dynamics simulationmetabolic diseasemolecular modelingsecondary amyloidosisserum amyloid Aserum amyloid P

Substanzen

Serum Amyloid A ProteinHomogentisic AcidProtein AggregatesAmyloidHomogentisate 1,2-Dioxygenase

Autor:innen und Institutionen

  • ONE-HEALTH Lab, Department of Biotechnology, Chemistry and Pharmacy, University of Siena Via Aldo Moro, 53100 Siena, Italy.
  • MetabERN, Department of Biotechnology, Chemistry and Pharmacy, University of Siena Via Aldo Moro, 53100 Siena, Italy.

ORCID-Profile: Pierfrancesco Mastroeni, Michela Geminiani, Luisa Frusciante, Anna Visibelli, Annalisa Santucci

Zitieren

APA

Mastroeni, P., Trezza, A., Geminiani, M., Frusciante, L., Visibelli, A., & Santucci, A. (2024). HGA Triggers SAA Aggregation and Accelerates Fibril Formation in the C20/A4 Alkaptonuria Cell Model. Cells. https://doi.org/10.3390/cells13171501

Vancouver

Mastroeni P, Trezza A, Geminiani M, Frusciante L, Visibelli A, Santucci A. HGA Triggers SAA Aggregation and Accelerates Fibril Formation in the C20/A4 Alkaptonuria Cell Model. Cells. 2024. doi:10.3390/cells13171501

BibTeX
@article{Mastroeni2024,
  author = {Mastroeni, Pierfrancesco and Trezza, Alfonso and Geminiani, Michela and Frusciante, Luisa and Visibelli, Anna and Santucci, Annalisa},
  title = {HGA Triggers SAA Aggregation and Accelerates Fibril Formation in the C20/A4 Alkaptonuria Cell Model},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13171501}
}
Kostenlos starten →